A detailed history of Omers Administration Corp transactions in Repligen Corp stock. As of the latest transaction made, Omers Administration Corp holds 1,844 shares of RGEN stock, worth $266,384. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,844
Previous 1,844 -0.0%
Holding current value
$266,384
Previous $232,000 18.1%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$120.0 - $182.95 $221,280 - $337,359
1,844 New
1,844 $232,000
Q4 2017

Feb 13, 2018

SELL
$32.53 - $38.92 $406,625 - $486,500
-12,500 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$36.98 - $46.06 $462,249 - $575,750
12,500
12,500 $479,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.02B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Omers Administration Corp Portfolio

Follow Omers Administration Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omers Administration Corp, based on Form 13F filings with the SEC.

News

Stay updated on Omers Administration Corp with notifications on news.